Barclays PLC Raises Holdings in Transcat, Inc. (NASDAQ:TRNS)

Barclays PLC lifted its position in shares of Transcat, Inc. (NASDAQ:TRNS) by 393.0% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 15,130 shares of the scientific and technical instruments company’s stock after purchasing an additional 12,061 shares during the quarter. Barclays PLC owned about 0.16% of Transcat worth $1,826,000 as of its most recent filing with the SEC.

A number of other institutional investors have also modified their holdings of the company. DekaBank Deutsche Girozentrale acquired a new position in shares of Transcat during the second quarter worth $40,000. nVerses Capital LLC acquired a new position in Transcat in the 3rd quarter worth $60,000. Quest Partners LLC purchased a new position in Transcat in the second quarter valued at about $109,000. US Bancorp DE increased its stake in shares of Transcat by 15.6% in the third quarter. US Bancorp DE now owns 1,547 shares of the scientific and technical instruments company’s stock worth $187,000 after buying an additional 209 shares during the last quarter. Finally, Captrust Financial Advisors acquired a new stake in shares of Transcat in the 3rd quarter valued at about $201,000. Hedge funds and other institutional investors own 98.34% of the company’s stock.

Transcat Stock Performance

NASDAQ TRNS opened at $106.01 on Friday. The stock has a market cap of $975.19 million, a price-to-earnings ratio of 53.54 and a beta of 0.70. The firm’s 50 day moving average price is $107.62 and its two-hundred day moving average price is $118.04. Transcat, Inc. has a twelve month low of $94.29 and a twelve month high of $147.12.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The company had revenue of $67.83 million for the quarter, compared to analyst estimates of $70.30 million. During the same period last year, the business earned $0.41 EPS. The company’s quarterly revenue was up 8.0% on a year-over-year basis. On average, research analysts forecast that Transcat, Inc. will post 1.76 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Northland Securities decreased their price objective on shares of Transcat from $130.00 to $110.00 and set a “market perform” rating for the company in a report on Wednesday, October 30th. HC Wainwright restated a “buy” rating and issued a $156.00 price target on shares of Transcat in a research note on Tuesday, October 29th. Craig Hallum increased their price objective on Transcat from $113.00 to $125.00 and gave the stock a “buy” rating in a report on Thursday, December 12th. Oppenheimer reiterated an “outperform” rating and set a $130.00 price objective (down previously from $155.00) on shares of Transcat in a research note on Wednesday, October 30th. Finally, StockNews.com lowered Transcat from a “hold” rating to a “sell” rating in a report on Tuesday, October 29th. One analyst has rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus target price of $130.25.

Transcat Profile

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.